Related Experiment Videos
Malignant melanoma: treatment of metastatic meningitis with intrathecal interferon alpha-2b
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
[French ccAFU guidelines - update 2020-2022: prostate cancer].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
[French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
[French ccAFU guidelines - Update 2018-2020: Prostate cancer].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2019
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate French ccAFU guidelines – Update 2018–2020: Prostate cancer
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
[CCAFU french national guidelines 2016-2018 on prostate cancer].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2016
What does addressing cancer inequalities really mean? Five principles that can drive global action.
European journal of cancer (Oxford, England : 1990)·2026
Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial.
European journal of cancer (Oxford, England : 1990)·2026
Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women.
European journal of cancer (Oxford, England : 1990)·2026
Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors.
European journal of cancer (Oxford, England : 1990)·2026
Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive prostate cancer from the ARASENS trial.
European journal of cancer (Oxford, England : 1990)·2026
Lazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib.
European journal of cancer (Oxford, England : 1990)·2026
Efgartigimod for acute attacks of brainstem MOGAD followed by mycophenolate mofetil maintenance: a case report.
Frontiers in immunology·2026